SinoMab BioScience Limited (3681.HK)
HKD 1.03
(-1.9%)
HKD 1.03
(-1.9%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 422 Thousand CNY | -89.53% |
| 2022 | 4.03 Million CNY | -84.87% |
| 2021 | 26.65 Million CNY | 108.91% |
| 2020 | 12.76 Million CNY | 0.0% |
| 2019 | - CNY | -100.0% |
| 2018 | 1.48 Million CNY | 1364.96% |
| 2017 | -117 Thousand CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.59 Million CNY | 0.0% |
| 2023 Q4 | -4.07 Million CNY | 0.0% |
| 2023 Q2 | 7.52 Million CNY | 0.0% |
| 2023 FY | 422 Thousand CNY | -89.53% |
| 2022 FY | 4.03 Million CNY | -84.87% |
| 2022 Q4 | -3.42 Million CNY | 0.0% |
| 2022 Q2 | 7.45 Million CNY | 0.0% |
| 2021 Q2 | - CNY | 0.0% |
| 2021 Q4 | 26.65 Million CNY | 0.0% |
| 2021 FY | 26.65 Million CNY | 108.91% |
| 2020 Q2 | - CNY | 0.0% |
| 2020 FY | 12.76 Million CNY | 0.0% |
| 2020 Q4 | 12.76 Million CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | -100.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 1.48 Million CNY | 1364.96% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2017 FY | -117 Thousand CNY | 0.0% |
| 2017 Q1 | - CNY | 0.0% |
| 2017 Q2 | - CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2016 Q4 | - CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Uni-Bio Science Group Limited | 392.81 Million HKD | 99.893% |
| CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 99.955% |